Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
data
46%
populations
43%
glucose
36%
risks
35%
brain
35%
levels
29%
metabolism
26%
nervous system diseases
25%
diseases
24%
comparative evaluations
19%
sex
17%
nerves
17%
plasma
17%
obesity
15%
volume
15%
people
14%
netherlands
14%
nmr imaging
14%
environment
13%
damage
12%
interactions
12%
incidents
12%
food
12%
quality of life
12%
biological markers
12%
women
11%
liver
11%
vessels
11%
diabetes mellitus
11%
intake
10%
performance
10%
diet
10%
men
10%
pain
10%
prediction
9%
layers
9%
learning
9%
stiffness
9%
fibers
9%
genetics
9%
inflammation
9%
range
9%
regression analysis
9%
education
9%
control
8%
insulin
8%
patients
8%
sleep
7%
methylation
7%
concentration
7%
cardiovascular diseases
7%
tissues
7%
dna
7%
noise
7%
adjustments
7%
fats
6%
symptoms
6%
sensitivity
6%
income
6%
blood pressure
6%
thickness
6%
sulfur
6%
amino acids
6%
humans
6%
mediation
5%
aging
5%
tools
5%
speed
5%
processing
5%
skin
5%
precision
5%
excretion
5%
proteins
5%
devices
5%
Keyphrases
Maastricht
100%
Type 2 Diabetes Mellitus (T2DM)
47%
Pre-diabetes (pre-DM)
22%
Dementia
17%
Netherlands
16%
Obesity
14%
Neurodegeneration
12%
Cognitive Functioning
10%
Food Environment
10%
Socioeconomic Position
9%
Diabetes
9%
Normal Glucose Tolerance
8%
Cognitive Function
8%
Glucose Metabolism Status
8%
Cerebral Small Vessel Disease (cSVD)
7%
Advanced Glycation End Products
7%
Cognitive Performance
7%
Habitual Intake
7%
Multi-cohort
7%
Structural Brain Damage
7%
Social Cohesion
7%
Quality of Life
7%
DNA Methylation (DNAm)
6%
Lifestyle Factors
6%
Cognitive Decline
6%
Sulfur Amino Acids
6%
Population-based
6%
Population-based Cohort
6%
Diet Quality
6%
Non-associated
5%
Inflammation
5%
Dementia Research
5%
Cardiometabolic Disease
5%
Mediating Role
5%
Microvascular Dysfunction
5%
Body Mass Index
5%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
43%
Impaired Glucose Tolerance
26%
Glucose Metabolism
24%
Diabetes
13%
Neurodegeneration
13%
Heart Rate Variability
11%
Biological Marker
11%
Arterial Stiffness
9%
Gray Matter
9%
Cross Sectional Study
8%
Meta-Analysis
8%
Corneal Nerve
8%
Cohort Analysis
7%
Magnetic Resonance Imaging
7%
Neuropathy
7%
Alzheimer's Disease
7%
Advanced Glycation End-Product
7%
Urinary System
5%
Diseases
5%
Physical Activity
5%
Fatty Liver
5%
Glycemic
5%
Linear Regression Analysis
5%
Insulin Sensitivity
5%